A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.
Yishan SunSergiu P PaşcaThomas PortmannCarleton GooldKathleen A WorringerWendy GuanKaren C ChanHui GaiDaniel VogtYing-Jiun J ChenRong MaoKarrie ChanJohn Lr RubensteinDaniel V MadisonJoachim HallmayerWendy M Froehlich-SantinoJonathan A BernsteinRicardo E DolmetschPublished in: eLife (2016)
Dravet Syndrome is an intractable form of childhood epilepsy associated with deleterious mutations in SCN1A, the gene encoding neuronal sodium channel Nav1.1. Earlier studies using human induced pluripotent stem cells (iPSCs) have produced mixed results regarding the importance of Nav1.1 in human inhibitory versus excitatory neurons. We studied a Nav1.1 mutation (p.S1328P) identified in a pair of twins with Dravet Syndrome and generated iPSC-derived neurons from these patients. Characterization of the mutant channel revealed a decrease in current amplitude and hypersensitivity to steady-state inactivation. We then differentiated Dravet-Syndrome and control iPSCs into telencephalic excitatory neurons or medial ganglionic eminence (MGE)-like inhibitory neurons. Dravet inhibitory neurons showed deficits in sodium currents and action potential firing, which were rescued by a Nav1.1 transgene, whereas Dravet excitatory neurons were normal. Our study identifies biophysical impairments underlying a deleterious Nav1.1 mutation and supports the hypothesis that Dravet Syndrome arises from defective inhibitory neurons.
Keyphrases
- induced pluripotent stem cells
- spinal cord
- end stage renal disease
- ejection fraction
- endothelial cells
- chronic kidney disease
- newly diagnosed
- prognostic factors
- traumatic brain injury
- genome wide
- spinal cord injury
- gene expression
- climate change
- risk assessment
- dna methylation
- copy number
- pluripotent stem cells
- functional connectivity
- resting state
- blood brain barrier
- gestational age
- drug induced